Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.

J HeckertHenry P Parkman

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2017)

Domperidone improves symptoms of gastroparesis, reducing overall gastroparesis symptom severity and decreasing early satiety, postprandial fullness, and nausea. GCSI-DD is useful to document efficacy of therapy for gastroparesis.

Keyphrases

physical activity
blood glucose
type diabetes
adipose tissue
patient reported
weight loss